Beijing Commercial Daily News (Reporter Dong Liang Ding Ning) On the evening of November 30, Skyray Instrument (300165) received a letter of concern from the Shenzhen Stock Exchange, and the Shenzhen Stock Exchange requested the company to explain the business model and development of Bessie’s new crown detection reagent products.
It is understood that from November 29 to 30, Skyray Instrument’s stock price rose by a limit of 43.98% for two consecutive trading days, reaching the standard for abnormal stock price fluctuations. Recent questions from investors of Interactive Easy show that investors are more concerned about the company’s wholly-owned subsidiary Shanghai Beixi Biotechnology Co., Ltd. (hereinafter referred to as “Beixi Bio”) new crown detection reagent products. On November 29th, Skyray Instruments answered a number of investor questions in Interactive Easy, saying that Bessie Bio “is actively promoting the overseas sales of new crown virus antigen detection reagents” and “part of the detection reagent products have obtained CE certification.” At present, there is a small amount of sales mainly in Europe and some countries in the Americas.”
In this regard, the Shenzhen Stock Exchange requires the company to explain in detail the business model and development of Bessie’s new crown detection reagent products, including but not limited to the research and development model, procurement model, production model, sales model, main product categories and their research and development stages, and research and development investment. , Product use and efficacy, market expansion and the specific country where sales are achieved, the production capacity, capacity utilization rate, sales volume, unit price, sales revenue, net profit, current order status of related products in the most recent year, etc.
In addition, the letter of concern shows that in the third quarters of 2019, 2020 and 2021, the net profit of Skyray Instruments after non-deduction was -1.72 million yuan, -36.08 million yuan and -1.8 million yuan, respectively. In this regard, the Shenzhen Stock Exchange requires the company to combine operating income structure, operating performance, industry policies, market demand and environmental changes, etc., to explain whether the company’s business fundamentals have undergone major changes, whether the recent stock price increase matches the company’s fundamentals, and whether it is consistent with the company’s fundamentals. The range of changes of listed companies in the industry is consistent, and combined with the valuation, price-earnings ratio, and stock price changes of listed companies in the same industry, the large increase in stock prices in the short term fully reminds the risk.Return to Sohu to see more
Editor:
Disclaimer: The opinions of this article only represent the author himself. Sohu is an information publishing platform. Sohu only provides information storage space services.
.